Rising pet adoption coupled with rising concerns regarding pet health and prevalence of bacterial infection, especially in dogs, is anticipated to further propel the market growth. Leptospirosis, staphylococcal infection, bacterial ear infection, actinomycosis, and nocardiosis are some of the most common forms of infections in pets. Moreover, pets are susceptible to bacterial diseases, such as plague, brucellosis, and Lyme disease. According to the qualitative report by the CDC in 2018, cats are more prone to plague than dogs and can pass on the infection to humans as well.
This report contains market size and forecasts of Pets Anti-infective Drugs in Global, including the following market information:
Global Pets Anti-infective Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pets Anti-infective Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pets Anti-infective Drugs include Boehringer Ingelheim, Zoetis, Merck, Elanco, Bayer, Virbac, Ceva Sante Animale, Vetoquinol and Bimeda Animal Health and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pets Anti-infective Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pets Anti-infective Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pets Anti-infective Drugs Market Segment Percentages, by Type, 2021 (%)
Injection
Oral
Others
Global Pets Anti-infective Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Pets Anti-infective Drugs Market Segment Percentages, by Application, 2021 (%)
Dog
Cat
Others
Global Pets Anti-infective Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Pets Anti-infective Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pets Anti-infective Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pets Anti-infective Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boehringer Ingelheim
Zoetis
Merck
Elanco
Bayer
Virbac
Ceva Sante Animale
Vetoquinol
Bimeda Animal Health
Chanelle